Infectious and Respiratory Disease Research Group (Legionella)

Miquel Sabria
Maria Luisa Pedro-Botet

This multidisciplinary group made up of researchers and medical staff of the Infectious Diseases and International Health Unit of the Germans Trias Hospital (HGT). It works closely with staff of the the Pneumology Services at the Parc Tauli Hospitals. The group has been carrying out collaborative research for more than 15 years and is part of the Instituto Carlos III research networks, at first in the network Respira (RTIC CO3/11) and later in the Networked Biomedical Research Centre (CIBER) created in 2007. It is also a consolidated research group as recognized by the Generalitat of Catalonia (AGAUR: 2014 SGR801).

The general aim of the group is to carry out clinical and translational research on infectious and respiratory diseases.

Publications of the Infectious and Respiratory Disease Research Group

Research lines

Infectious Diseases

  • Research into community acquired and nosocomial Pneumonia
  • Research into bacteraemias and infectious endocarditis
  • Research into primary immunodeficiencies
  • Research into Chagas disease and other tropical diseases
  • Research into International Health

Legionella

The Legionella Research Group is a research group of the Autonomous University of Barcelona (Code: 1818).

  • Research into epidemiological, clinical, therapeutic and preventive aspects of Legionnaires' Disease
  • Molecular and phenotypic epidemiology of Legionella
  • Development of new detection, diagnostic and typing methods for Legionella

Chronic Obstructive Pulmonary Disease (COPD)

Description of the bronquial microbioma and the bronquial inflammatory response associated with the particular clinical variants of different cohorts of patients:

  • Early-COPD: Multi-centre study, an initial diagnostic COPD cohort
  • DELICATO: Multi-centre study of severe COPD and the characteristics of fragility due to frequent exacerbations
  • BRN COPD: Multi-centre study of the respiratory microbiome in MCOPD focussed on the identification of and intervention for determinants for readmittance and mortality after an episode of serious exacerbated COPD
  • EX-COPD: Multi-centre study of the respiratory microbiome in and its relation to the the immune system and the intestinal microbiome

Cancer

The group acts as a Corporate Research Program Coordinator (PCI) for Lung Cancer in the Instituto Carlos III On-line Network for Respiratory Disease, CIBERES Enfermedades Respiratorias.  The project includes the creation of a biobank for tumour tissue, non-tumour tissue and peripheral blood from patients with Stage I or II non-small cell lung cancer in order to be able to detect new predictive and prognostic biomarkers.

Members of the Group

Miguel Sabrià Leal(ELIMINAR), Group Leader and PI
Lourdes Mateu, Medical Services HGT
Noemí Parraga, Researcher
Maria Luisa Pedro-Botet(ELIMINAR), Head of Section, PI
Sara Quero, Research Staff
Esteban Reynaga(ELIMINAR), Medical Services HGT
Silvia Rour(ELIMINAR)e, Medical Services HGT
Nieves Sopena

Ongoing Projects

Nuevos productos de bajo coste para la desinfección en sistemas de agua: estudio de la eficiencia sobre Legionella

ISCIII Code: PI16/01347
Principlal Investigator: ML Pedro-Botet                                                                                           
Start Date: 01/01/2017
End Date: 31/12/2019


PICAT (Plataforma Integral per al Control d'Arbovirosis a Catalunya)

Ministry of Health, Government of Catalonia, Code:SLT002/16/004662015I054
PI:
Start date:
End date: 2019


Grup Consolidat reconegut per la Generalitat de Catalunya

Code:2017 SGR 716
Principlal Investigators: Eduard Monsó & Miguel Sabria                                                                                         
Start Date: 01/01/2017
End Date: 31/12/2019

More information

Contact

Noemí Párraga Niño; IGTP Edifici Mar, P1-12

(+34) 93 497 8680

nparraga(ELIMINAR)@igtp.cat